84 results
10-Q
2024 Q1
EX-10.3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
for the purpose of (i) providing any services to such entity or (ii) diverting or encouraging such entities or Clients of the Company to discontinue … or indirectly, or to an attorney, and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (2) is made in a complaint
10-Q
2024 Q1
EX-10.2
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
indicate its consent to, approval of or acquiescence in any of the foregoing; or any corporate or other action is taken by the Borrower for the purpose
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
of our employees and us, for the purpose of employing or engaging the services of such employee or soliciting such employee to become an employee … , and the purpose of these programs is to either expedite the development or review of important new drugs and biologics to get them to patients more quickly than
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
of our employees and us, for the purpose of employing or engaging the services of such employee or soliciting such employee to become an employee … , and the purpose of these programs is to either expedite the development or review of important new drugs and biologics to get them to patients more quickly than
10-K
2023 FY
EX-97.1
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
to take any and all actions necessary or appropriate to carry out the purpose and intent of this Policy (the “Authorized Officers”) (other than
10-K
EX-19.1
ng5x1az5wj02p
16 Apr 24
Annual report
4:48pm
10-K
5v1503ro
16 Apr 24
Annual report
4:48pm
S-8
EX-4.5
eftfff vr2o
12 Apr 24
Registration of securities for employees
7:22pm
S-8
EX-4.6
7xy9wy df
12 Apr 24
Registration of securities for employees
7:22pm
S-8
tdq gxgpg9e3md
12 Apr 24
Registration of securities for employees
7:22pm
S-8
EX-107
3cu meg8hnha40s6
12 Apr 24
Registration of securities for employees
7:22pm
8-K
EX-1.1
vhw5wmc4
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
8-K
EX-3.2
qzv2cci8j7318
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
8-K
EX-3.1
y5txi45v7jfr
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
8-K
EX-4.1
8h3bpizzn87k8
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
424B4
0oble0y45ndkoq7
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
hvna069ppeb8a 8cn
20 Feb 24
Prospectus supplement with pricing info
5:28pm
POS EX
EX-5.1
85axq2ad5 oivelc3x
15 Feb 24
Additional exhibits for listing
9:56pm